Dermatol. praxi. 2019;13(2):103-106 | DOI: 10.36290/der.2019.016

Morbus Fabry – skin and soft‑tissue manifestations

MUDr. Gabriela Dostálová, Ph.D.
Centrum pro Fabryho nemoc
II. interní klinika – kardiologie a angiologie VFN a 1. LF UK

Fabry disease (FD, OMIM 301500) or Fabry-Anderson disease, is a rare, X chromosome-linked progressive lysosomal storage disease. Mutations in the GLA gene are resposible for deficiency of alpha-galactosidase A (alpha-gal A), which is the cause of the accumulation of neutral glycosphingolipids, mainly globotriaosylceramide (Gb3), within various tissue types. The disease brings on variety of neurologic, renal, cardiovascular, ophthalmologic or dermatologic symptoms. The disease can manifests at any age from early childhood to late aduthood. A precise cooperation of a multidisciplinary team is necessary for an early diagnosis of Fabry disease, with dermatologist representing a crucial part of such teams.

Keywords: Fabry disease, soft‑tissue manifestations, angiokeratomas, sweating abnormalities, lymphoedema

Published: June 10, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dostálová G. Morbus Fabry – skin and soft‑tissue manifestations. Dermatol. praxi. 2019;13(2):103-106. doi: 10.36290/der.2019.016.
Download citation

References

  1. Germain DP. Fabry disease. Orphanet J Rare Dis, 2010: 5, 30. Go to original source... Go to PubMed...
  2. Hopkin RJ, Bissler J, Banikazemi M, et al. Characterization of Fabry disease in 352 pediatric patients in the Fabry Registry. Pediatr Res, 2008: 64(5), 550-555. Go to original source... Go to PubMed...
  3. Deegan PB, Baehner AF, Barba Romero MA, et al. Natural history of Fabry disease in females in the Fabry Outcome Survey. J Med Genet, 2006: 43(4), 347-352. Go to original source... Go to PubMed...
  4. Clarke JT. Narrative review: Fabry disease. Ann Intern Med, 2007: 146(6), 425-433. Go to original source... Go to PubMed...
  5. Spada M, Pagliardini S, Yasuda M, et al. High incidence of later-onset fabry disease revealed by newborn screening. Am J Hum Genet, 2006: 79(1), 31-40. Go to original source... Go to PubMed...
  6. Anderson W A case of "angeio-keratoma". Br J Dermatol. 1898; 10: 113-117.
  7. Fabry J. Ein Beitrag zur Kenntnis der Purpura haemorrhagica nodularis (Purpura papulosa haemorrhagica Hebra). Arch Dermatol Syphilol (Berlin). 1898; 43: 187-201. Go to original source...
  8. Ramaswami U, Whybra C, Parini R, et al. Clinical manifestations of Fabry disease in children: data from the Fabry Outcome Survey. Acta Paediatr, 2006: 95(1), 86-92. Go to original source... Go to PubMed...
  9. Ries M, Ramaswami U, Parini R, et al. The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents. Eur J Pediatr, 2003: 162(11), 767-772. Go to original source... Go to PubMed...
  10. Kanda A, Nakao S, Tsuyama S, et al. Fabry disease: ultrastructural lectin histochemical analyses of lysosomal depozits. Virchows Arch, 2000: 436(1), 36-42. Go to original source... Go to PubMed...
  11. Larralde M, Boggio P, Amartino H, et al. Fabry disease: a study of 6 hemizygous men and 5 heterozygous women with emphasis on dermatologic manifestations. Arch Dermatol, 2004:140(12), 1440-1446. Go to original source... Go to PubMed...
  12. Mohrenschlager M., Henkel V, Ring J. Fabry disease: more than angiokeratomas. Arch Dermatol, 2004: 140(12), 1526-1528. Go to original source... Go to PubMed...
  13. MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet,2001: 38(11), 750-760. Go to original source... Go to PubMed...
  14. Kanekura T, Fukushige T, Kanda A, et al. Immunoelectron-microscopic detection of globotriaosylceramide accumulated in the skin of patients with Fabry disease. Br J Dermatol, 2005:153(3), 544-548. Go to original source... Go to PubMed...
  15. Jansen T, Bechara FG, Happle R, et al. Angiokeratoma circumscriptum without metabolic disease. Acta Paediatr Suppl. 2006; 451: 121.
  16. Bersano A, Lanfranconi S, Valcarenghi C, et al. Neurological features of Fabry disease: clinical, pathophysiological aspects and therapy. Acta Neurol Scand, 2012: 126(2), 77-97. Go to original source... Go to PubMed...
  17. Cable WJ, Kolodny EH, Adams RD. Fabry disease: impaired autonomic function. Neurology, 1982: 32(5), 498-502. Go to original source... Go to PubMed...
  18. Ries M, Gupta S, Moore DF, et al. Pediatric Fabry disease. Pediatrics, 2005: 115(3), e344-355. Go to original source... Go to PubMed...
  19. Kokotis P, Uceyler N, Werner C, et al. Quantification of sweat gland innervation in patients with Fabry disease: A case-control study. J Neurol Sci, 2018: 390, 135-138. Go to original source... Go to PubMed...
  20. Amann-Vesti BR, Gitzelmann G, Widmer U, et al. Severe lymphatic microangiopathy in Fabry disease. Lymphat Res Biol, 2003: 1(3), 185-189. Go to original source... Go to PubMed...




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.